<Record>
<Term>Y 90 Anti-CEA Monoclonal Antibody</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Radioimmunoconjugate</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Radiopharmaceutical Compound/Radioimmunoconjugate/Y 90 Anti-CEA Monoclonal Antibody</ClassificationPath>
<BroaderTerm>Radioimmunoconjugate</BroaderTerm>
<BroaderTerm>Radiopharmaceutical Compound</BroaderTerm>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Y 90 Anti-CEA Monoclonal Antibody</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<Synonym>Y 90 Anti-CEA Monoclonal Antibody</Synonym>
<Synonym>Y90 Anti-CEA Monoclonal Antibody</Synonym>
<Synonym>Yttrium Y90 Anti-CEA monoclonal antibody</Synonym>
<Description>A radioimmunoconjugate of monoclonal antibody against human carcinoembryonic antigen (CEA), labeled with yttrium 90 (Y-90). CEA is over-expressed in many tumor cell types. Using anti-CEA monoclonal antibody to deliver beta emitting nuclide Y-90 to CEA-positive cells results in tissue specific cytotoxicity.</Description>
<Source>NCI Thesaurus</Source>
</Record>
